Strategy Notes
Strong alignment on sector (biotech/pharma AI), geography (EU-based), female founder advantage, and funding amount (€2.5M within their range). However, the venture is currently at pre-seed/PoC stage (TRL 4–5), while EIC Accelerator targets TRL 6–8 (beyond PoC, near market-ready). Applicant is also not yet incorporated. Recommend applying after fine-tuning roadmap completion, Servier validation, and formal incorporation—likely 18–24 months out.